PharmGKB summary: oxycodone pathway, pharmacokinetics
- PMID: 30222708
- PMCID: PMC6602093
- DOI: 10.1097/FPC.0000000000000351
PharmGKB summary: oxycodone pathway, pharmacokinetics
Conflict of interest statement
Conflict of interest: RBA is a stockholder in Personalis Inc. and 23andMe, and a paid advisor for Karius
Figures
References
-
- Olkkola KT, et al., Does the pharmacology of oxycodone justify its increasing use as an analgesic? Trends Pharmacol Sci, 2013. 34(4): p. 206–14. - PubMed
-
- Falk E, Eukodal, ein neues Narkotikum. Munchener Medizinische Wochenschrift, 1917. 20: p. 381–384.
-
- Riley J, et al., Oxycodone: a review of its use in the management of pain. Curr Med Res Opin, 2008. 24(1): p. 175–92. - PubMed
-
- Poyhia R and Seppala T, Liposolubility and protein binding of oxycodone in vitro. Pharmacol Toxicol, 1994. 74(1): p. 23–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
